You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 11, June 12, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (18)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hypertension
 •Neurology
 •Randomized Controlled Trial
 •Headache
 •Alert me on articles by topic

Headache in Mild-to-Moderate Hypertension and Its Reduction by Irbesartan Therapy

Lennart Hansson, MD; David H. G. Smith, MD; Richard Reeves, MD; Pablo Lapuerta, MD

Arch Intern Med. 2000;160:1654-1658.

Background  Although it is generally acknowledged to be a problem in severe hypertension, headache has not been consistently associated with mild-to-moderate hypertension.

Patients and Methods  In 7 randomized, double-blind, placebo-controlled trials, which included 2673 patients with mild-to-moderate hypertension (defined as seated diastolic blood pressure of 95-110 mm Hg), patients were randomized to receive once-daily treatment with irbesartan, an angiotensin II receptor blocker (n=1987), or placebo (n=686). The data were pooled and analyzed retrospectively to determine whether the level of hypertension was associated with headache and whether antihypertensive therapy reduced the incidence of headache.

Results  Factors found to be predictive of headache incidence were diastolic blood pressure, sex (female), and age (<50 years). In comparison with placebo, the use of irbesartan was associated with a significant reduction in the incidence of headache (P=.003).

Conclusions  These data suggest that mild-to-moderate hypertension is not asymptomatic and that the incidence of headache can be reduced by antihypertensive treatment with a favorable adverse effect profile.


From the Division of Clinical Hypertension Research, Institute for Geriatrics, Uppsala Universitët, Uppsala, Sweden (Dr Hansson); Memorial Research Medical Clinic, Long Beach, Calif (Dr Smith); and Pharmaceuticals Research Institute, Bristol-Myers Squibb Co, Princeton, NJ (Drs Reeves and Lapuerta).


RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(11):1708-1709.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Headaches and the Treatment of Blood Pressure: Results From a Meta-Analysis of 94 Randomized Placebo-Controlled Trials With 24 000 Participants
Law et al.
Circulation 2005;112:2301-2306.
ABSTRACT | FULL TEXT  

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
Law et al.
BMJ 2003;326:1427.
ABSTRACT | FULL TEXT  

Headache, Hypertension, and Irbesartan Therapy
Bensenor et al.
Arch Intern Med 2001;161:775-776.
FULL TEXT  

Prevalence of headache in an elderly population: attack frequency, disability, and use of medication
Prencipe et al.
J. Neurol. Neurosurg. Psychiatry 2001;70:377-381.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.